Live Breaking News & Updates on Michael Gait

Stay updated with breaking news from Michael gait. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

PepGen Appoints Caroline Godfrey, Ph.D. to the Company's Scientific Advisory Board

PepGen Appoints Caroline Godfrey, Ph.D. to the Company’s Scientific Advisory Board - read this article along with other careers information, tips and advice on BioSpace ....

United States , United Kingdom , Caroline Godfrey , Laurence Watts , James Mcarthur , Gwendolyn Schanker , Matthew Wood , University College London , Lifesci Communications , University Of Oxford , Gilmartin Group , Research Council Of United Kingdom , Pepgen Inc , University Of Sheffield , Scientific Advisory , Senior Vice President , Scientific Advisory Board , Chief Executive Officer , Medical Research Council , United Kingdom Research , Postdoctoral Researcher , Project Manager , Professor Matthew Wood , Michael Gait , Founded Pepgen , Chief Executive ,

PepGen Appoints Caroline Godfrey, Ph.D. to the Company's Scientific Advisory Board

PepGen Appoints Caroline Godfrey, Ph.D. to the Company's Scientific Advisory Board
forextv.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from forextv.com Daily Mail and Mail on Sunday newspapers.

United States , United Kingdom , Caroline Godfrey , Laurence Watts , James Mcarthur , Gwendolyn Schanker , Matthew Wood , University College London , Lifesci Communications , University Of Oxford , Gilmartin Group , Research Council Of United Kingdom , Pepgen Inc , University Of Sheffield , Scientific Advisory , Senior Vice President , Scientific Advisory Board , Chief Executive Officer , Medical Research Council , United Kingdom Research , Postdoctoral Researcher , Project Manager , Professor Matthew Wood , Michael Gait , Founded Pepgen , Chief Executive ,

PepGen Inc (PEPG) Appoints Caroline Godfrey to its Board

PepGen Inc (PEPG) Appoints Caroline Godfrey to its Board
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United States , United Kingdom , Caroline Godfrey , James Mcarthur , Matthew Wood , University College London , University Of Oxford , Research Council Of United Kingdom , Pepgen Inc , University Of Sheffield , Scientific Advisory , Senior Vice President , Scientific Advisory Board , Chief Executive Officer , Medical Research Council , United Kingdom Research , Postdoctoral Researcher , Project Manager , Professor Matthew Wood , Michael Gait , Founded Pepgen , Chief Executive , Enhanced Delivery Oligonucleotide ,

PepGen raises $113M to challenge Sarepta in DMD, build neuromuscular and neurologic pipeline

PepGen raises $113M to challenge Sarepta in DMD, build neuromuscular and neurologic pipeline
fiercebiotech.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fiercebiotech.com Daily Mail and Mail on Sunday newspapers.

United States , Sarepta Exondys , James Mcarthur , Matthew Wood , Oxford Sciences Innovation , Qatar Investment Authority , Like Exondys , Michael Gait , Cureduchenne Ventures , Viking Global Investors , Deerfield Management , ஒன்றுபட்டது மாநிலங்களில் , ஜேம்ஸ் மகார்‌தர் , மேத்யூ மரம் , ஆக்ஸ்ஃபர்ட் அறிவியல் கண்டுபிடிப்பு , கத்தார் முதலீடு அதிகாரம் , மைக்கேல் நடை , வைக்கிங் உலகளாவிய முதலீட்டாளர்கள் , தீர்ப்பியல்ட் மேலாண்மை ,

PepGen Announces Appointment of James McArthur, Ph.D., as President and Chief Executive Officer

Press release content from PR Newswire. The AP news staff was not involved in its creation.
PepGen Announces Appointment of James McArthur, Ph.D., as President and Chief Executive Officer
February 4, 2021 GMT
PepGen Logo
BOSTON and OXFORD, England, Feb. 4, 2021 /PRNewswire/ PepGen, a biotechnology company focused on transforming the care of patients with neuromuscular diseases through the enhanced delivery of therapeutic oligonucleotides, today announced the appointment of James McArthur, Ph.D., as President and Chief Executive Officer (CEO). Dr. McArthur brings more than 25 years of experience as a co-founder of numerous biotech companies focused on rare disease therapeutics. He joins the PepGen team at a time of rapid growth following its successful $45 million Series A financing at the end of 2020, which was led by RA Capital Management with participation from Oxford Sciences Innovation (OSI), CureDuchenne Ventures, and the University of Oxford. ....

United States , United Kingdom , Massachusetts Institute Of Technology , Caroline Godfrey , James Mcarthur , Prnewswire Pepgen , Chris Ashton , Ramin Farzaneh , Matthew Wood , Synovex Adheron , University Of California , Oxford Sciences Innovation , Laboratory Of Molecular Biology In Cambridge , University Of Oxford , Pepgen Inc , Academic Co , Mcgill University , Advisor At Oxford Sciences Innovation , Chief Executive Officer , Cureduchenne Ventures , Academic Co Founder , Senior Vice President , Professor Matthew Wood , Michael Gait , Molecular Biology , Massachusetts Institute ,